Money

By now most every investor has heard the name, Seattle Genetics (SGEN) a once small, still developmental biotechnology company with a well recognized oncology drug in Adcetris. Many analysts that cover the stock including the well-respected bio-blogger PropThink are concerned these investors are over-valuing the company in light of flat revenue projections for all of 2013.Apologists, including Prohost Biotech, usually refer to the generous partnership agreements and evolving pipeline of wholly owned compounds to deflect criticism away. That strategy is becoming increasingly more difficult to justify in light of a $4.42bn market-cap that is 21.5x projected 2013 revenues. The question then becomes, are shareholders so in love with Seattle Genetics that they are blind to its bloated figure or are they privy to something the rest of us simply can't comprehend?To answer this question effectively we would need to find out what's driving the bulls by

Al Madrigal questions former MSNBC pundit Dylan Ratigan about leaving cable news for the less angry world of hydroponic farming. The Daily Show with Jon StewartGet More: Daily Show Full Episodes,Indecision Political Humor,The Daily Show on Facebook Tuesday May 21, 2013 (05:39)

Gold and silver have been taking a pretty good beating of late. In fact, over the last 1 month, 3 months, and 6 months IAU/GLD is down 8%, 11%, and 14% respectively, while over the same time horizons SLV is down 15%, 23% and 25% respectively.In the midst of this ongoing collapse in the precious metals market, there is a lot of contradictory analysis between precious metals bulls and bears taking place. Nonetheless, despite the debates there is a fair amount of common ground between the bulls and bears. In this article we will consider three of the most salient points of the discussion. Finally, we will conclude by looking at a related investment idea regarding the leverage ETF, Proshares Ultrashort Silver (ZSL): Paper v Physical While the demand for "paper" precious metals is very weak, the demand for physical precious metals is at record levels. In the

To create business, to stimulate creativity and help customers beat the crisis, BEING France and Bergère de France, the leading French spinner, created the first ever customer-generated wool coupon. Customers were invited to pick one of 4 coupon designs (-5%, -10%, -15% and -20%) from a brochure, use their cast-off yarn to knit the coupon according to their level of expertise, and bring it back to their Bergère de France boutique to get the discount on their next purchase. “The better you knit, the more you save.” Advertising Agency: BEING, Paris, France Chief Creative Officer Alasdhair Macgregor Hastie Creative Director: Thierry Buriez Art Director: Nicolas Comastri Copywriter: Jérémy Jamet

Australian startup, Airtasker, is keen to expand out of its home country into Southeast Asia, which it says hasn’t been touched by large competitors yet. The year-old startup provides job matching for freelancers and employers, similar to what oDesk and Elance do. For its first steps outside of Australia, its first port of call will be Singapore, where it wants to hire two country managers. Airtasker joins a scene that already has a few huge competitors. oDesk, for example, has been around since 2005. Last year, the company raised $15 million, making its total funding $45 million to date. The site processes $300 million in jobs on an annual basis. Some early oDesk employees also founded Rev.com, which in March announced $4.5 million in Series A funding. Another big competitor, Elance, raised $16 million in funding early last year as well, as its business has continued to grow in the past two years. 650,000 new job postings were listed on the site in 2011, it said. But big as these sites are, they don’t seem to have made a huge impact on freelancers in Southeast Asia. A quick search for freelancers in Singapore on oDesk showed 248 listings out of 742,113. Hong Kong showed a dismal 84, Kuala Lumpur 7 and Bangkok 31. Jonathan Lui and Tim Fung, Airtasker’s founders While it appears indeed untouched by the large sites, it could just mean that the freelancing scene is a lot less vibrant in Asia, with the majority of workers preferring full-time jobs. It could also be that fewer freelancers rely on online matching sites to get their jobs, as well. Airtasker’s founder and CEO, Tim Fung, said temp jobs in the region are less organized into verticals. He said some common jobs in Asia include handing out flyers at a train station, or a one-day PA. These can’t really be categorized by industry, and Airtasker has organized its job ads and job seeker profiles in a broader fashion, so that more matches can be made by both sides. The bulk of Airtasker’s workers, for now, are based in Australia, and its upward trajectory does indicate some sort of pent-up demand on the freelancing scene. Airtasker now processes about $120,000 worth of jobs per month. Fung hinted that Airtasker will announce a partnership with a global jobs network soon. “I think that’s an indication that the larger ‘mainstream’ job scene is taking part-time job listings more seriously,” he said. The site will also roll out a new design in about a months’ time, with a “responsive design” adapting to mobile interfaces when accessed through tablets and phones. This is going to make a lot of sense as it expands into Southeast Asia, where mobiles are more popular in emerging markets compared with PCs. About 40 percent of users accessing Airtasker’s site are already coming in on mobile devices, said Fung. Airtasker has seven people, including co-founders Fung and Jonathan Lui. It’s raised $1.5 million so far.

Filed under: InvestingPeriodically, new research shows that use and consumer "engagement" with Facebook Inc. (NASDAQ: FB) has fallen and is usually replaced by time people spend on some alternative social media. If all the research were accurate, put together it would paint a picture of Facebook's near-term demise. But Facebook, at least for the time being, is flourishing. The latest data about Facebook use, particularly in contrast to Twitter, is from Pew Internet. The report titled "Teens, Social Media, and Privacy" is an assessment of the use of the two huge social media sites: Teen Twitter use has grown significantly: 24% of online teens use Twitter, up from 16% in 2011. And: Focus group discussions with teens show that they have waning enthusiasm for Facebook, disliking the increasing adult presence, people sharing excessively, and stressful "drama," but they keep using it because participation is an important part of overall teenage socializing. The Pew study is much more about how teens manage privacy on the Web, but its observations about Twitter and Facebook are too incendiary to stay out of the headlines. Investors are left with measuring Facebook's one billion users with how much they use it. The size of the Facebook user base is extremely seductive to the marketers that ultimately will determine its financial fate. Facebook's inventory is almost endless - by some estimates it has a quarter of all the online display ads in the United States. But many marketers are more interested in features that allow users to share marketing messages with one another, which makes advertising activity active and not passive as it is on other media, like TV. In theory, people who show ads to their friends are better potential customers than people who see ads and immediately forget them. Because Facebook is a public company, it has to defend itself as often as possible with statistics that argue it is still the most important social medium of all, no matter what other research shows. Most recently, Facebook launched a new campaign about the huge numbers of people who use it. Among the data it released in its new "Facebook's Growth in the Past Year" are that the company reported 4.5 billion "likes" per day in May, up 67% from the same measurement from August of last year. In addition, 4.5 billion pieces of content were shared each day in May, up 94% from last August. And active users have hit 1.11 billion this month, up 23% from March of last year. Facebook does not say why each of the comparisons is not identical, based on which months it used from the past. Perhaps August comparisons are better in some cases, and March comparisons in others. It does open up the possible accusation that Facebook has "gamed" the numbers to make them look as good as possible. In the end, there is not enough information about an erosion of Facebook's audience, a drop in user interest, for shareholders to panic. The company's sales continue to rise at an impressive pace. It is still the number one, undisputed leader among social media sites. Pew might have cast another bit of doubt on Facebook's future, but it is not one that it likely to linger. Another study about Facebook's audience and that of its competitors will be along soon enough. And that, like others, is not likely to be conclusive. Filed under: 24/7 Wall St. Wire, Research Tagged: FB Read | Permalink | Email this | Linking Blogs | Comments

Accenture Helps NHS Radiologists Exchange Medical Images in the Cloud New system enables clinicians to access images in real-time across hospitals/medical facilities in Southwest England LONDON--(BUSINESS WIRE)-- Accenture (NYS: ACN) has completed the deployment of a cloud-based Radiology Information System (RIS) for five hospitals and 23 facilities within the National Health Service (NHS) in Southwest England. Using Accenture Clinical Services, the new platform enables clinicians to store, access and exchange patient and diagnostic information from virtually anywhere, over a highly secure infrastructure. The deployment project -- from signing contracts to going live -- took just 10 weeks and included migration of data from the old systems to the new Accenture solution. "The growing demand for imaging means that radiologists are confronted with increasing workloads and the challenge of processing larger amounts of data," said Matt Oakley who leads Accenture's Medical Imaging Practice in the United Kingdom and Ireland. "As the NHS national IT contracts draw to a close, this cloud-based solution will enable clinicians across the region to share patient data, which can be crucial in urgent cases, such as stroke or major trauma. It also will enable trusts to concentrate on providing the best care to patients, rather than having to worry about maintaining an IT system." Accenture worked with Healthcare Software Systems (HSS) to deploy their RIS solution to enable radiologists and clinicians to securely share and manage patient diagnostic data, radiology reports, appointments and administrative functions with confidence. The new RIS solution replaces an existing system and is part of a five-year strategy. "Our group of hospitals are undertaking a major replacement of PACS (picture archiving and communications system) and RIS systems under an aggressive timetable in the lead up to the end of the national contracts," said Andy Blofield, director of Plymouth ICT Shared. "For RIS, the most important considerations in choosing a new vendor were confidence in the service and patient safety and the continued ability to share data across organizations. With the rapid deployment and support services it provided, Accenture has demonstrated that we made the right choice." The increasing demand for cloud computing in medical imaging is expected to grow 26 percent annually through 2018, according to an Accenture study. Roughly 73 percent of healthcare organizations are expected to shift medical imaging data into the cloud, in some capacity, while 32 percent currently use some form of cloud computing for imaging, according to the study. The shift from analog to digital images has resulted in exponential growth in the amount of data that must be stored. Learn more about Accenture's Insight Driven Health, Accenture Clinical Services and Delivering Public Service for the Future. About Accenture Accenture is a global management consulting, technology services and outsourcing company, with approximately 261,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012. Its home page is www.accenture.com. Accenture Clinical Services Through Accenture Clinical Services, we help health systems enhance healthcare delivery and, ultimately, improve patient outcomes. Our services combine extensive clinical practices with healthcare IT capabilities, including electronic medical records and medical imaging systems. Accentu

NTRR Expands Opportunities in California's $1.3 Billion Medical Marijuana Market SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a growth-oriented provider of all-natural wellness solutions, opened talks this week with a second mergers and acquisitions target in California's booming $1.3 billion medical marijuana (MMJ) market. NTRR is finalizing a new joint venture with an emerging MMJ company developing a suite of cannabinoid delivery-system products, including smokeless vaporizers. Now, NTRR expects to sign a letter of intent in the coming days to partner with a second company specializing in oral delivery systems for cannabinoids, as well. "California is on the cutting edge of MMJ innovations, and we're working very aggressively to develop the business relationships we need to become a dominant player in this emerging market," Mr. Jim said. "Thorough research has convinced us of a strong and rising demand for alternative MMJ delivery systems such as capsules, throat sprays, transdermal patches and more. We're very excited about the possibility of partnering with an emerging leader in this sector who can assist us in bringing these high-value products to the patients who need them." Smoke-free cannabinoid delivery systems have exploded in popularity with MMJ users in recent years because they deliver the same therapeutic effects of the drug without the potential dangers and restrictions associated with smoking. NTRR is pursuing an ambitious mergers and acquisitions strategy to help introduce the next wave of new MMJ innovations and technologies to the explosive $1.7 billion market that is continuing to grow across the country. NTRR has made California the staging point for its efforts to build market share in the industry by basing its new medicinal cannabis subsidiary—Cannabis Technologies, Inc.—in Los Angeles. Since voters approved California's medical marijuana program in 1996, the state has become home to the largest MMJ market in the U.S., with an estimated 750,000 qualified patients. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA) and Terra Tech Corp. (PINK: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For more information on NTRR's initiatives, please visit www.neutracorp.com/investors.html. About Neutra Corp. Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com/investors.html. Notice Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof. Neutra Corp.Sydney Jim, 713

PEOPLE - Leonardo DiCaprio aurait flashé sur elle. Elle, c'est Cara Delevingne , une Anglaise de 20 ans habituée de la jet set et nouvelle star des podium. La top model aurait eu l'audace de rembarrer l'acteur américain lors d'une soirée à Cannes donnée après la projection de Gatsby le magnifique.Lire aussi : » Cara Delevingne, la nouvelle star des podiumsMore...

Jamie's Italian, the Jamie Oliver restaurant group, has hired Karmarama as its first advertising agency, after a three-way pitch against Antidote and CheethamBell JWT.